Dr. David Furman is Director of the Stanford 1,000 Immunomes Project at Stanford School of Medicine, Associate Professor at the Buck Institute for Research on Aging and Chief of the AI Platform at the same institute. He obtained his Doctoral degree in immunology (summa cum laude) from the School of Medicine, University of Buenos Aires, Argentina, for his work on cancer immune-surveillance. During his Postdoctoral training at the laboratory of Professor Mark M Davis (Stanford), he conducted cutting-edge research in Data Science and Systems Immunology to predict clinical outcomes using multi-omics technologies in large human cohorts. The aim was to answer scientific questions with strong potential for translational medicine, including the effect of immunity in age-related disease and longevity...
David Furman, director of the 1000 Immunomes Project at Stanford, is at the forefront of space longevity research. Collaborating with NASA, Furman studies the risks associated with space flight and aging, aiming to develop countermeasures. Leveraging partnerships with SpaceX and Axiom, Furman collects biological data from astronauts during and after space flight. Using microgravity simulation, Furman’s team accelerates aging in organoids to study functional changes and identify drug candidates for age-related dysfunction. Access to space data and ground analogues helps map findings to diseases of aging. Furman also emphasizes the need to improve infrastructure for clinical trials in space.